Temasek-backed Allozymes secures $15m for European expansionBy admin | May 14, 2024 | Leave a Comment Allozymes’ platform can analyze over 20 million enzyme variants daily.
Sources: the EU plans to charge Meta under the DMA this week, focusing on Meta's pay or consent model where users pay for an ad-free Facebook and Instagram (Javier Espinoza/Financial Times)
